{"protocolSection":{"identificationModule":{"nctId":"NCT03352310","orgStudyIdInfo":{"id":"UCB-HIEA-01"},"organization":{"fullName":"Mononuclear Therapeutics Ltd.","class":"INDUSTRY"},"briefTitle":"Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia","officialTitle":"Umbilical Cord Blood Mononuclear Cell Bank in Hong Kong and Treatment of Neonatal Cerebral Ischemia and Anemia - Part IV Clinical Trial"},"statusModule":{"statusVerifiedDate":"2018-06","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-04-16","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2020-06-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2020-12-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2017-11-15","studyFirstSubmitQcDate":"2017-11-21","studyFirstPostDateStruct":{"date":"2017-11-24","type":"ACTUAL"},"lastUpdateSubmitDate":"2018-06-05","lastUpdatePostDateStruct":{"date":"2018-06-07","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Mononuclear Therapeutics Ltd.","class":"INDUSTRY"},"collaborators":[{"name":"Chinese University of Hong Kong","class":"OTHER"},{"name":"China Spinal Cord Injury Network","class":"NETWORK"}]},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study is to investigate the feasibility and safety of autologous umbilical cord blood transfusion to treat the newborn infants with presence of clinical indications of neonatal hypoxic-ischemia encephalopathy (HIE) and anemia. Umbilical cord blood (UCB) is collected following labor and is transfused intravenously within 48 hours after the birth. Newborn infant without UCB available recieves the standard care will be enrolled as control group.\n\nFollowing the autologous UCB transfusion in the study group or standard care in the control group, HIE subjects will be followed for 2 years for survival and neurodevelopmental outcomes and anemia subjects will be followed for 6 months to assess the survival and change of hematocrit and hemoglobin levels."},"conditionsModule":{"conditions":["Hypoxic-Ischemic Encephalopathy","Hypoxia Neonatal","Cerebral Ischemia of Newborn","Anemia, Neonatal"],"keywords":["umbilical cord blood"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"Study Group - autologous umbilcial cord blood transfusion\n\nControl Group - standard care","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":40,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Study Group","type":"EXPERIMENTAL","description":"autologous UCB transfusion","interventionNames":["Biological: autologous umbilical cord blood (UCB)"]},{"label":"Control Group","type":"OTHER","description":"standard care","interventionNames":["Procedure: standard care"]}],"interventions":[{"type":"BIOLOGICAL","name":"autologous umbilical cord blood (UCB)","description":"autologous UCB transfusion to the newborn infants presence of HIE and/or anemia within 48 hours after the birth","armGroupLabels":["Study Group"]},{"type":"PROCEDURE","name":"standard care","description":"standard care procedure to the newborn infants presence of HIE and/or anemia","armGroupLabels":["Control Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"HIE: Mortality","description":"Mortality Rate of the HIE Subjects","timeFrame":"6 months"},{"measure":"Anemia: Change from Baseline Hematocrit","description":"Change from Baseline Hematocrit of the Anemia Subjects","timeFrame":"48 hours, 1 week, 3 months, 6 months"}],"secondaryOutcomes":[{"measure":"HIE: HINE","description":"Hammersmith Infant Neurological Examination (HINE) of the HIE Subjects","timeFrame":"6 months, 1 year and 2 years"},{"measure":"HIE: HNNE","description":"Hammersmith Neonatal Neurological Examination (HNNE) of the HIE Subjects","timeFrame":"-1 day, 3 months (before discharge)"},{"measure":"HIE: GMDS","description":"Griffiths Mental Development Scale (GMDS) of the HIE Subjects","timeFrame":"6 months, 1 year and 2 years"},{"measure":"HIE: CBCL","description":"Child Behavior Checklist for Attention Deficit of the HIE Subjects","timeFrame":"2 years"},{"measure":"HIE: Q-CHAT","description":"Quantitative Checklist for Autism in Toddlers of the HIE Subjects","timeFrame":"2 years"},{"measure":"Anemia: hemoglobin","description":"Change from Baseline hemoglobin of the Anemia Subjects","timeFrame":"48 hours, 1 week, 3 months and 6 months"},{"measure":"Anemia: Oxygenation level","description":"Change from Baseline SpO2 of the Anemia Subjects","timeFrame":"48 hours, 1 week"},{"measure":"Anemia: Oxidative Stress Level","description":"Change of Baseline Isoprostane of the Anemia Subjects","timeFrame":"48 hours, 1 week, 3 months, and 6 months"},{"measure":"Anemia: Requirements of Packed Cell Transfusion","description":"Frequency of Requirements of Packed Cell Transfusion by the Anemia Subjects","timeFrame":"6 months"}],"otherOutcomes":[{"measure":"Incidence of Adverse Event","description":"Safety outcomes are Incidence of Adverse Events","timeFrame":"2 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* evidence of asphyxiation, defined by 5-minute Apgar score ≤ 5;\n* evidence of HIE, defined by UCB pH \\<7.15 or base excess ≤ 10mM;\n* subjects with HIE confirmed by clinical features and initial investigations;\n* subjects with evidence of anemia, defined by hematocrit \\< 40% or hemoglobin ≤ 13g/dL within the first 96 hours of life;\n* obtain the informed consent from parents\n\nExclusion Criteria:\n\n* congestive cardiac failure;\n* microcephaly, anencephaly, encephalocele, or other abnormality\n* conjoint twins;\n* chromosomal disorders\n* fetal alcohol syndrome\n* spinal bifida or other neural tube defects\n* subjects have other neurological deficit conditions\n* polycythemia\n* congenital hematological malignancy\n* investigator decision","healthyVolunteers":false,"sex":"ALL","maximumAge":"48 Hours","stdAges":["CHILD"]},"contactsLocationsModule":{"centralContacts":[{"name":"Simon Lam, MD","role":"CONTACT","phone":"+852 35052851","email":"hshslam@cuhk.edu.hk"},{"name":"Ronald Wang, MD","role":"CONTACT","phone":"+852 35052810"}],"overallOfficials":[{"name":"Simon Lam, MD","affiliation":"Chinese University of Hong Kong","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"The Chinese University of Hong Kong","status":"RECRUITING","city":"Sha Tin","country":"Hong Kong","contacts":[{"name":"Simon Lam, M.D.","role":"CONTACT","phone":"+852 35052851"},{"name":"Simon Lam, MD","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Ronald Wang, MD","role":"SUB_INVESTIGATOR"},{"name":"Chi Kong Li, MD","role":"SUB_INVESTIGATOR"},{"name":"Eva Fung, MD","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":22.38333,"lon":114.18333}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000020925","term":"Hypoxia-Ischemia, Brain"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000000740","term":"Anemia"},{"id":"D000000751","term":"Anemia, Neonatal"},{"id":"D000007511","term":"Ischemia"},{"id":"D000000860","term":"Hypoxia"}],"ancestors":[{"id":"D000006402","term":"Hematologic Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000012818","term":"Signs and Symptoms, Respiratory"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000002534","term":"Hypoxia, Brain"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000020521","term":"Stroke"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"},{"id":"D000007232","term":"Infant, Newborn, Diseases"}],"browseLeaves":[{"id":"M10233","name":"Ischemia","asFound":"Ischemia","relevance":"HIGH"},{"id":"M3875","name":"Hypoxia","asFound":"Hypoxia","relevance":"HIGH"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Cerebral Ischemia","relevance":"HIGH"},{"id":"M5484","name":"Brain Ischemia","asFound":"Cerebral Ischemia","relevance":"HIGH"},{"id":"M3760","name":"Anemia","asFound":"Anemia","relevance":"HIGH"},{"id":"M3771","name":"Anemia, Neonatal","asFound":"Anemia, Neonatal","relevance":"HIGH"},{"id":"M4894","name":"Brain Diseases","asFound":"Encephalopathy","relevance":"HIGH"},{"id":"M22350","name":"Hypoxia-Ischemia, Brain","asFound":"Hypoxic Ischemic Encephalopathy","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M9180","name":"Hematologic Diseases","relevance":"LOW"},{"id":"M15313","name":"Signs and Symptoms, Respiratory","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M5473","name":"Hypoxia, Brain","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M9966","name":"Infant, Newborn, Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"BC15","name":"Blood and Lymph Conditions"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"}]}},"hasResults":false}